Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for Excessive Daytime Sleepiness in OSA Patients Refusing CPAP (HAROSA2)
NCT01072968Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Oct 2011
- Primary completion
- May 2014
- Countries
- 1
01
Overview
A Phase 3 trial of pitolisant in Excessive Daytime Sleepiness (EDS), sponsored by Bioprojet. Started Oct 2011; status: completed.
02
Drugs
pitolisant
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT01072968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072968.